2016-03-09T00:00:00.000-05:00
United States,-0.387785
materially adverse facts,-0.445542
substantive review,-0.447454
United States Food,-0.387785
class period,-0.508087
File letter,-0.41762
Translarna.  The FDA,-0.447454
artificially inflated prices,-0.60916
misleading statements,-0.699046
New Drug Application,-0.447454
GLOBE NEWSWIRE,0.239567
similar outcome,-0.720073
Prior results,-0.720073
market capitalization loss,-0.554206
Drug Administration,-0.387785
